Cabergoline use for pituitary tumors and valvular disorders

Endocrinology and Metabolism Clinics of North America
Renata S AuriemmaAnnamaria Colao

Abstract

Cabergoline (CAB) is widely used for the medical treatment of pituitary tumors, particularly those associated with hormone hypersecretion. Whether treatment with CAB is associated with an increased risk of clinically relevant cardiac valve disease in patients with pituitary tumors is still debated. In most studies, CAB has been found not associated with an increased risk of significant valvulopathy, and no correlation has been shown between valvular abnormalities and CAB duration or cumulative dose. This review provides an overview of the studies reporting on the outcome of CAB in terms of cardiac valve disease in patients with pituitary tumors.

References

Aug 1, 1997·The Annals of Thoracic Surgery·G OhtsukaY Sakomura
Nov 10, 1998·Lancet·A Colao, G Lombardi
May 3, 2005·European Journal of Pharmacology·Sven JähnichenHeinz H Pertz
May 18, 2006·Endocrine Reviews·Mary P GillamAnnamaria Colao
May 6, 2008·European Journal of Endocrinology·Patrizio LancellottiAlbert Beckers
May 23, 2008·European Journal of Endocrinology·Agatha A van der KlaauwAlberto M Pereira
Aug 7, 2008·The Journal of Clinical Endocrinology and Metabolism·Annamaria ColaoGaetano Lombardi
Aug 19, 2008·European Journal of Endocrinology·V J MoyesW M Drake
Sep 11, 2008·Endocrine-related Cancer·Annamaria ColaoSilvia Savastano
Nov 11, 2008·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Jessica K DevinLewis S Blevins
Jan 27, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Frank Andersohn, Edeltraut Garbe
Jan 15, 2010·European Journal of Endocrinology·M LafeberP M J Zelissen
Feb 5, 2010·The Journal of Clinical Endocrinology and Metabolism·Elena ValassiBeverly M K Biller
Apr 28, 2011·Clinical Endocrinology·Alessandra Ferri CasiniMônica Roberto Gadelha
Jun 1, 2011·Clinical Endocrinology·Annamaria Colao, Ludovica F S Grasso
Jan 27, 2012·The Journal of Clinical Endocrinology and Metabolism·C E HighamP J Trainer
Mar 8, 2012·Pituitary·I BernabeuM Marazuela
Jun 23, 2012·The Journal of Clinical Endocrinology and Metabolism·Luigi MaionePhilippe Chanson
Apr 12, 2013·Clinical Endocrinology·Trevor A HowlettUNKNOWN UK Acromegaly Register Study Group (UKAR-3)
Jul 5, 2013·European Journal of Endocrinology·Renata S AuriemmaAnnamaria Colao
Nov 5, 2013·The Journal of Clinical Endocrinology and Metabolism·W M DrakeUNKNOWN UK Dopamine Agonist Valvulopathy Group
Apr 30, 2014·Revista Española De Cardiología·Juan G Córdoba-SorianoJesús Salas-Nieto

❮ Previous
Next ❯

Citations

Sep 5, 2015·Endocrine·Sean NoronhaAshley Grossman
Feb 9, 2016·Expert Opinion on Drug Safety·Renata S AuriemmaAnnamaria Colao
Apr 18, 2016·Journal of Endocrinological Investigation·A G Ambrogio, F Cavagnini
Jun 29, 2016·Expert Opinion on Pharmacotherapy·Filippo MaffezzoniAndrea Giustina
Aug 16, 2016·Pituitary·Dawn Shao Ting Lim, Maria Fleseriu
Nov 11, 2017·Endocrine·Roberto Salvatori
Nov 1, 2015·Expert Review of Endocrinology & Metabolism·Ferdinand Roelfsema, Gerrit van den Berg
May 18, 2019·Drugs·José Miguel Hinojosa-AmayaMaria Fleseriu
Dec 19, 2019·Journal of Clinical Medicine·Irene SamperiNiki Karavitaki
Mar 6, 2017·International Journal of Oncology·So-Hye HongBeum-Soo An
Jul 14, 2017·Clinical Diabetes and Endocrinology·Daniel Cuevas-RamosMaria Fleseriu
Sep 7, 2018·Frontiers in Endocrinology·Odelia Cooper, Yona Greenman
Aug 12, 2018·Journal of Endocrinological Investigation·R PaluiH Durgia
May 23, 2020·Therapeutics and Clinical Risk Management·Giuliana CoricaFederico Gatto
Aug 1, 2018·Expert Review of Endocrinology & Metabolism·Martin J Rutkowski, Manish K Aghi
Aug 20, 2020·Expert Review of Endocrinology & Metabolism·Cristina CapatinaMaria Fleseriu
Sep 16, 2020·The Journal of Clinical Endocrinology and Metabolism·Camille Hage, Roberto Salvatori
Apr 20, 2021·Frontiers in Oncology·Han YangJianwei Li
Sep 11, 2021·World Journal of Surgical Oncology·Qizhi ZhangChuan Xu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
Cindy ZadikoffPaula Rochon
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
Cindy ZadikoffAnthony Lang
© 2022 Meta ULC. All rights reserved